H.R. 7839 · 116th Congress

Continuing Access to In-Home IVIG Act

Stage
In committee
Introduced
2020-07-29
Latest action
2020-07-29 · Introduced in House

Summary

Continuing Access to In-Home IVIG Act

This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.